{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:01:52Z","timestamp":1791388912157,"version":"4.3.3"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Previous studies have shown that elevated progesterone (P4) levels on human chorionic gonadotropin (HCG) trigger days may affect endometrial tolerance. However, no standardized threshold has been established for the impact of late follicular phase P4 on clinical outcomes. This study aimed to assess the influence of P4 levels on the day of HCG trigger in a follicular long-term protocol on clinical outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This retrospective study analyzed 889 fresh\n                      <jats:italic>in vitro<\/jats:italic>\n                      fertilization-embryo transfer cycles, each involving a single top-quality cleavage-stage embryo (CSE) or blastocyst transfer. Univariate and multivariate logistic regression analyses, threshold effect analysis, and curve fitting were carried out.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A significant correlation was identified between the P4 level and both the clinical pregnancy rate ([CPR] OR: 0.54, 95% CI: 0.37 \u2013 0.81,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.003) as well as the ongoing pregnancy rate ([OPR] OR: 0.68, 95% CI: 0.46 \u2013 0.99,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.047) in blastocyst transfer. However, no significant relationship was found between P4 level and CPR or OPRs in CSE transfer. The OPR displayed a linear relationship with the P4 level in CSEs. In blastocyst transfer, the CPR followed a parabolic pattern, initially declining gradually at higher P4 levels and then dropping sharply when P4 reached \u2265 1.0 ng\/mL. On the other hand, the OPR displayed a reverse U-shaped curve, increasing with P4 levels up to 1.0 ng\/mL before declining at higher levels. The OPR significantly declined when the P4 level exceeded 1.0 ng\/mL.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In blastocyst transfer cycles, the P4 level on the HCG trigger day shows a curvilinear association with the outcomes of pregnancy. The optimal threshold was found to be as 1.0 ng\/mL.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2025.1593079","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T05:12:25Z","timestamp":1763615545000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical impact of progesterone levels on HCG trigger day in a follicular long-term IVF protocol"],"prefix":"10.3389","volume":"16","author":[{"given":"Xiao","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanrong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhen","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menglan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangli","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2014.995620","article-title":"The individualized choice of embryo transfer timing for patients with elevated serum progesterone level on the HCG day in IVF\/ICSI cycles: a prospective randomized clinical study","volume":"31","author":"Yang","year":"2015","journal-title":"Gynecol Endocrinol: Off J Int Soc Gynecol Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deab160","article-title":"Is a freeze-all policy the optimal solution to circumvent the effect of late follicular elevated progesterone? A multicentric matched-control retrospective study analysing cumulative live birth rate in 942 non-elective freeze-all cycles","volume":"36","author":"Racca","year":"2021","journal-title":"Hum Reprod"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dey031","article-title":"Impact of late-follicular phase elevated serum progesterone on cumulative live birth rates: is there a deleterious effect on embryo quality","volume":"33","author":"Racca","year":"2018","journal-title":"Hum Reprod"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.5935\/1518-0557.20220023","article-title":"Serum progesterone on the day of human chorionic gonadotropin (hCG) trigger as a predictor of in-vitro fertilization (IVF) outcome - a retrospective analysis of seven years","volume":"27","author":"Yadav","year":"2023","journal-title":"JBRA Assit Reprod"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmt014","article-title":"Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60\u2013000 cycles","volume":"19","author":"Venetis","year":"2013","journal-title":"Hum Reprod Up"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1186146","article-title":"Duration of late-follicular elevated progesterone and in vitro fertilization outcomes in pituitary down-regulation treatment cycles","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)58273-9","article-title":"Elevated progesterone levels in the late follicular phase do not predict success of in vitro fertilization-embryo transfer","volume":"65","author":"Abuzeid","year":"1996","journal-title":"Fertil Steri"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0246440","article-title":"The impact of preovulatory versus midluteal serum progesterone level on live birth rates during fresh embryo transfer","volume":"16","author":"Benmachiche","year":"2021","journal-title":"PloS One"},{"key":"B9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12884-020-03495-6","article-title":"Progesterone levels predict pregnancy outcomes in individuals with fallopian tube associated infertility","volume":"21","author":"Bo","year":"2021","journal-title":"BMC Preg Childbirth"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1177\/0300060513489480","article-title":"Comparative study of pregnancy outcomes between day 3 embryo transfer and day 5 blastocyst transfer in patients with progesterone elevation","volume":"41","author":"Li","year":"2013","journal-title":"J Int Med Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-021-06304-3","article-title":"Serum progesterone level above 0.85 ng\/mL and progesterone\/estradiol ratio may be useful predictors for replacing cleavage-stage with blastocyst-stage embryo transfer in fresh IVF\/ICSI cycles without premature progesterone elevation","volume":"305","author":"Tokgoz","year":"2022","journal-title":"Arch Gynecol Obstet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.4274\/jtgga.2017.0012","article-title":"Blastocyst transfer does not improve cycle outcome as compared to D3 transfer in antagonist cycles with an elevated progesterone level on the day of hCG","volume":"18","author":"Demirel","year":"2017","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.547684","article-title":"The role of hCG triggering progesterone levels: A real-world retrospective cohort study of more than 8000 IVF\/ICSI cycles","volume":"11","author":"De Cesare","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deu151","article-title":"Live birth rates after IVF are reduced by both low and high progesterone levels on the day of human chorionic gonadotrophin administration","volume":"29","author":"Santos-Ribeiro","year":"2014","journal-title":"Hum Reprod"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S385362","article-title":"Slightly elevated progesterone on HCG trigger day has an impact on pregnancy outcomes of fresh single blastocyst transfer cycles under an early follicular phase prolonged protocol cycle","volume":"14","author":"Wei","year":"2022","journal-title":"Int J Wom Health"},{"key":"B16","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12978-022-01371-4","article-title":"Effect of slightly elevated progesterone on hCG trigger day on clinical pregnancy rate in GnRH-ant IVF\/ICSI cycles","volume":"19","author":"Zhao","year":"2022","journal-title":"Reprod Health"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1080\/01443615.2022.2151345","article-title":"Elevated serum progesterone levels on the hCG trigger day have a negative impact on the live birth rate in the first fresh IVF-ET cycle","volume":"42","author":"Jiang","year":"2022","journal-title":"J Obstetri Gynaecol: J Institute Obstetrics Gynaecol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/j.fertnstert.2015.02.038","article-title":"Are good patient and embryo characteristics protective against the negative effect of elevated progesterone level on the day of oocyte maturation","volume":"103","author":"Hill","year":"2015","journal-title":"Fertil Steril"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dez091","article-title":"Clinically significant intra-day variability of serum progesterone levels during the final day of oocyte maturation: a prospective study with repeated measurements","volume":"34","author":"Gonz\u00e1lez-Foruria","year":"2019","journal-title":"Hum Reprod"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2014.10.017","article-title":"Comparison of progesterone measurement on day of, and day after, HCG administration in IVF-embryo transfer cycles","volume":"30","author":"Liu","year":"2015","journal-title":"Reprod BioMed Onl"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S437794","article-title":"Effect of elevated progesterone levels on hCG trigger day on clinical pregnancy outcome in short-acting gnRHa downregulated cycles","volume":"15","author":"Jiang","year":"2023","journal-title":"Int J Wom Health"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2022.07.007","article-title":"Adverse impact of elevated progesterone levels on human chorionic gonadotropin trigger day on blastocyst transfer outcomes in gonadotropin-releasing hormone agonist cycles","volume":"276","author":"Kong","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1593079\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T06:39:35Z","timestamp":1765262375000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1593079\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":22,"alternative-id":["10.3389\/fendo.2025.1593079"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1593079","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"article-number":"1593079"}}